Haematology Flashcards
Describe Amyloidosis
A group of disorders characterised by extracellular deposition of a protein in abnormal fibrillar form, which is resistant to degeneration.
Can be primary (AL amyloid) or Secondary (AA amyloid) or familial.
Diagnosis is made with biopsy and postive Congo Red staining with red-green birefringence under polarised light microscopy.
What are Bence Jones proteins
Ig light chains excreted by kidney in excess in some patients with myeloma.
What are the causes of macrocytic anaemias?
Megaloblastic causes: Folate deficiency, B12 deficiency, anti-folate drugs e.g (phenytoin)
Normoblastic causes: alcohol, liver disease, hypothyroidism, pregnancy, reticulocytosis, myelodysplasia, cytotoxic drugs,
What are the causes of microcytic anaemias?
- iron deficiency anaemia (most common)
- thalassaemia
- sideroblastic anaemia (very rare)
What are some causes of a normocytic anaemia?
- acute blood loss
- anaemia of chronic disease
- renal failure
- bone marrow failure
- hypothyroidism (may be macrocytic)
- Haemolysis ( may be macrocytic)
- pregnancy
Describe iron-deficiency anaemia, it’s causes, diagnostic tests and treatment
Commonest cause of anaemia with microcytic hypochromic RBC’s
Causes: •blood loss e.g menorrhagia or GI bleeding •poor diet •malabsorption • hookworm in tropics
Signs: conjunctival pallor, lethargy, koilonychia, atrophic glossitis, angular cheilosis
Tests: FBC shows decreased MCV, MCH and ferritin (confirms diagnosis)
Treatment: ferrous sulphate 200mg BD PO follow up FBC if no response consider sideroblastic anaemia if Hb improves but MCV still low consider thalassaemia
What are the Side effects of oral ferrous sulphate?
- nausea
- abdominal discomfort
- diarrhoea or constipation
- black stools
Describe anaemia of chronic disease (secondary anaemia)
2nd most common anaemia after IDA most common anaemia in inpatients Due to 3 problems:
•poor use of iron in erythropoiesis
•cytokine-induced shortening of RBC survival
•decreased production of and response to erythropoietin
tests: FBC shows normocytic anaemia with normal or raises ferritin.
Describe myeloproliferative disorders
Causes by proliferation of a clone of haemopoetic myeloid stem cells in the marrow.
Classified depending on the cell type which is proliferating:
RBC - polycythaemia rubra Vera
WBC - chronic myeloid leukaemia
PLT - essential thrombocythaemia
Fibroblasts - myelofibrosis
What are some causes of thrombocytopenia?
May be due to decreased marrow production:
•aplastic anaemia
•megaloblastic anaemia
•marrow infiltration (e.g. Myeloma, leukaemia)
•marrow suppression (cytotoxics, radiotherapy)
Or may be due to excess destruction of platelets: -immune causes: •ITP •SLE •CLL -Non-immune causes: •TTP or HUS •DIC •hypersplenism
Describe Immune/Idiopathic Thrombocytopenic Purpura (ITP), its symptoms, tests, and management.
Caused by anti-platelet antibodies, may be acute (commonly self-limiting disease in children ~2 weeks post infection) or chronic (seen mainly in young/middle-aged women).
Symptoms:
- Acute ITP presents wth bruising, purpura, petechiae. Usually history of recent gastroenteritis or URTI.
- Chronic ITP presents with varying history of bleeding, purpura, epistaxis, menhorragia.
Tests: bone marrow biopsy shows increased megakaryocytes and anti platelet antibodies
Treatment:
- none if mild, gradual resolution over 3 months.
- if symptomatic or platelets less than 20, immunosuppression to keep platelets above 30 e.g Prednisolone 1mg/kg/d
- if no response or relapse splenectomy cures
Describe disseminated intravascular coagulation, it’s causes, and treatment
Widespread activation of coagulation leading to consumption of clotting factors and platelets with increased risk of bleeding. Fibrin strands fill small vessels Haemolysing RBCs.
Causes: malignancy, sepsis, trauma, obstetric events
Treatment:
- replace platelets if less than 50, cryoprecipitate to replace fibrinogen, FFP to replace coagulation factors.
- Activated protein C reduces mortality in DIC with severe sepsis or multi-organ failure.
Describe MyeloDysplastic Syndrome (MDS)
A heterogenous group of disorders that manifest as marrow failure with risk of life-threatening infection and bleeding.
May be primary or secondary due to chemotherapy or radiotherapy. 30% transform to acute leukaemia.
Ix: pancytopenia, increased marrow cellularity, ringed sideroblasts
Rx: multiple transfusions Erythropoietin +/- G-CSF Immunosuppressives (ciclosporin or antithymocyte globulins) Allogenic SCT Thalidomide analogues eg lenalidomide
What are the main types of Leukaemia?
Leukaemia divides into 4 main types depending on the cell line involved.
Lymphoid:
- Acute Lymphoblastic Leukaemia (ALL)
- Chronic Lymphocytic Leukaemia (CLL)
Myeloid:
- Acute Myeloid Leukaemia (AML)
- Chronic Myeloid Leukaemia (CML)
Describe tumour lysis syndrome, its risk factors and preventative measures.
Caused by a massive destruction of cells leading to release of K+, Urate, and then kidney injury.
Increased risk if levels of LDH are increased, Creatinine increased, urate increased or WCC >25
Prevention with high fluid intake and allopurinol pre-cytotoxics
Rasburicase - in high risk
Describe Acute Lymphoblastic Leukaemia and its tests
A malignancy of lymphoid cells, affecting B or T lymphocyte cell lines.
Uncontrolled proliferation of immature blast cells with BM failure and tissue infiltration
Commonest cancer of childhood.
Tests: Blasts cells
Describe Acute Myeloid Leukeamia and its tests
Neoplastic proliferation of blast cells derived from marrow myeloid elements. Associated with MDS. Symptoms are of Marrow failure and infiltration
DIC in APML t(15:17)
Tests: Auer rods, cytogenetic analysis
Describe Chronic Myeloid Leukaemia and its tests.
uncontrolled clonal proliferation of myeloid cells. It accounts for 15% of leukaemias. Occurs most often between 40-60yrs.
Philadelphia chromosome t(9:22) BCR/abl
Features: flaws, gout, bleeding, abdo discomfort
Tests: Increase WCC, low Hb
Increase urate, b12
BM hypercellular
Rx:imatinib/dasatanib/nilotinib. Hydroxycarbamide
Describe Chronic Lymphocytic Leukaemia and its tests.
Accumulation of mature B cells that have escaped programmed cell death
Rai staging
Can transform to Richter’s transformation
Tests: marked increased in lymphocytes, later autoimmune haemolysis, marrow infiltration
decreased Hb, Neutrophils and platelets.
Describe Sepsis (+/-Neutropenia), the sepsis six, and severe sepsis signs.
is a potentially fatal complication of anti-cancer treatment (particularly chemotherapy). Identify with Quick Sepsis Related Organ Failure Assessment (qSOFA) with 2 or more of the following.
- SBP less than 100mmHg
- RR >22
- new altered mental state.
Do the sepsis six:
- high-flow oxygen
- IV antibiotics
- IV Fluid challange (hartmann’s)
- Catheter and UO monitoring
- Serum lactate
- Blood cultures
Regularly screen for signs of severe sepsis:
- SBP less than 90mmHg
- SpO2 less than 90% despite high flow oxygen
- INR >1.5 or APTT >60s
- Plt less than 100
- UO less than 0.5ml/kg/hr
- lactate >2.0mmol/L